Reddy elected as a Fellow of the American Association of Pharmaceutical Scientists
Samba Reddy, Ph.D., R.Ph., professor of neuroscience and experimental therapeutics at Texas A&M Health Science Center College of Medicine, has been elected a Fellow of the American Association of Pharmaceutical Scientists (AAPS), a lifetime recognition and the highest professional honor of achievement in the pharmaceutical field. The award was presented by the AAPS President Dr. Marilyn Morris at the 2014 AAPS annual meeting and exposition in San Diego this month.
Reddy, a renowned expert in neurotherapeutics, was selected on the basis of “professional excellence as exemplified by a sustained level of superior and distinguished contributions that have a substantial impact in the pharmaceutical field.”
Reddy joined the Texas A&M faculty in 2008 and was previously honored by the National Institutes of Health (NIH) with the Fellow Award for Research Excellence in 2000. His work is centered on finding better medications for treatment of brain disorders such as epilepsy, brain injury and chemical neurotoxicity and he has made pioneering contributions that include development of a neurosteroid-replacement therapy for epilepsy, new epilepsy medication ganaxolone, and tonic inhibition therapy for persistent seizures and neurotoxicity. He successfully designed many model systems, treatment strategies and first-in-class agents for complex brain disorders.
Reddy is a member of several federal committees such as NIH, the Department of Defense and the United States Pharmacopeia. He also serves as editor-in-chief of the International Journal of Pharmaceutical Sciences and Nanotechnology.